Expert Opinion on Investigational Drugs, Volume 17, Issue 5 (2008)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 17, Issue 5 (2008)

See all volumes and issues
Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Volume 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994
Download citations Download PDFs Download issue

Editorial

Article
Selective thyromimetics for atherosclerosis and dyslipidaemia: another old target making progress
Keith Suckling
Pages: 615-618
Published online: 30 Apr 2008
AbstractforSelective thyromimetics for atherosclerosis and dyslipidaemia: another old target making progress | Full Text | References | PDF (147.6 KB)
  • 84 Views
  • 7 CrossRef citations
  • 0Altmetric

Reviews

Article
Osteoarthritic pain: a review of current, theoretical and emerging therapeutics
Simon J Read & Andy Dray
Pages: 619-640
Published online: 30 Apr 2008
AbstractforOsteoarthritic pain: a review of current, theoretical and emerging therapeutics | Full Text | References | PDF (554.4 KB)
  • 434 Views
  • 35 CrossRef citations
  • 0Altmetric
Article
Spleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis
Malini Bajpai PhD, Puneet Chopra PhD, Sunanda G Dastidar PhD & Abhijit Ray PhD
Pages: 641-659
Published online: 30 Apr 2008
AbstractforSpleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis | Full Text | References | PDF (6.6 MB)
  • 433 Views
  • 49 CrossRef citations
  • 0Altmetric
Article
Polymyxin B: a new strategy for multidrug-resistant Gram-negative organisms
Zhe Yuan MD & Vincent H Tam PharmD
Pages: 661-668
Published online: 30 Apr 2008
AbstractforPolymyxin B: a new strategy for multidrug-resistant Gram-negative organisms | Full Text | References | PDF (123.8 KB)
  • 408 Views
  • 36 CrossRef citations
  • 0Altmetric
Article
Pituitary-targeted medical therapy of Cushing's disease
Krystallenia I Alexandraki & Ashley B Grossman
Pages: 669-677
Published online: 30 Apr 2008
AbstractforPituitary-targeted medical therapy of Cushing's disease | Full Text | References | PDF (198.4 KB)
  • 116 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
Pharmacotherapy for erectile dysfunction
Andrew Feifer MD & Serge Carrier MD
Pages: 679-690
Published online: 30 Apr 2008
AbstractforPharmacotherapy for erectile dysfunction | Full Text | References | PDF (145.7 KB)
  • 93 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
Anti-nicotine abuse vaccines in the pipeline: an update
Erich H Cerny MD & Thomas Cerny MD
Pages: 691-696
Published online: 30 Apr 2008
AbstractforAnti-nicotine abuse vaccines in the pipeline: an update | Full Text | References | PDF (103.3 KB)
  • 103 Views
  • 21 CrossRef citations
  • 0Altmetric
Article
New promise and hope for treating hereditary angioedema
Bruce L Zuraw MD & Sandra C Christiansen MD
Pages: 697-706
Published online: 30 Apr 2008
AbstractforNew promise and hope for treating hereditary angioedema | Full Text | References | PDF (200.2 KB)
  • 135 Views
  • 19 CrossRef citations
  • 0Altmetric
Article
New tubulin targeting agents currently in clinical development
Robert O Carlson , PhD
Pages: 707-722
Published online: 30 Apr 2008
AbstractforNew tubulin targeting agents currently in clinical development | Full Text | References | PDF (239.2 KB)
  • 333 Views
  • 93 CrossRef citations
  • 0Altmetric

Review

Article
Indications and limitations of third-generation aromatase inhibitors
Per Eystein Lønning & Jürgen Geisler
Pages: 723-739
Published online: 30 Apr 2008
AbstractforIndications and limitations of third-generation aromatase inhibitors | Full Text | References | PDF (195.8 KB)
  • 116 Views
  • 14 CrossRef citations
  • 0Altmetric

Drug Evaluations

Article
Axitinib for renal cell carcinoma
Guru Sonpavde MD, Thomas E Hutson DO PharmD FACP & Brian I Rini MD
Pages: 741-748
Published online: 30 Apr 2008
AbstractforAxitinib for renal cell carcinoma | Full Text | References | PDF (219.1 KB)
  • 617 Views
  • 55 CrossRef citations
  • 0Altmetric

Drug Evaluation

Article
Doripenem: an expected arrival in the treatment of infections caused by multidrug-resistant Gram-negative pathogens
Garyphallia Poulakou MD & Helen Giamarellou MD PhD
Pages: 749-771
Published online: 30 Apr 2008
AbstractforDoripenem: an expected arrival in the treatment of infections caused by multidrug-resistant Gram-negative pathogens | Full Text | References | PDF (221.3 KB)
  • 196 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
Idraparinux: review of its clinical efficacy and safety for prevention and treatment of thromboembolic disorders
Paolo Prandoni, Daniela Tormene, Marica Perlati, Barbara Brandolin & Luca Spiezia
Pages: 773-777
Published online: 30 Apr 2008
AbstractforIdraparinux: review of its clinical efficacy and safety for prevention and treatment of thromboembolic disorders | Full Text | References | PDF (102.4 KB)
  • 106 Views
  • 23 CrossRef citations
  • 0Altmetric
Article
Gemifloxacin for community-acquired pneumonia
Hartmut M Lode MD PhD, Malina Schmidt-Ionas MD & Ralf Stahlmann MD PharmD PhD
Pages: 779-786
Published online: 30 Apr 2008
AbstractforGemifloxacin for community-acquired pneumonia | Full Text | References | PDF (130.3 KB)
  • 105 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Paromomycin in the treatment of leishmaniasis
Shyam Sundar & Jaya Chakravarty
Pages: 787-794
Published online: 30 Apr 2008
AbstractforParomomycin in the treatment of leishmaniasis | Full Text | References | PDF (135.6 KB)
  • 379 Views
  • 77 CrossRef citations
  • 0Altmetric
Article
Betahistine: what's new on the agenda?
Nir Barak MD
Pages: 795-804
Published online: 30 Apr 2008
AbstractforBetahistine: what's new on the agenda? | Full Text | References | PDF (174 KB)
  • 470 Views
  • 25 CrossRef citations
  • 0Altmetric
Article
Vernakalant – a promising therapy for conversion of recent-onset atrial fibrillation
Gerald V Naccarelli MD, Deborah L Wolbrette MD, Soraya Samii MD PhD, Javier E Banchs MD, Erica Penny-Peterson MD, Robert Stevenson MD & Mario D Gonzalez MD
Pages: 805-810
Published online: 30 Apr 2008
AbstractforVernakalant – a promising therapy for conversion of recent-onset atrial fibrillation | Full Text | References | PDF (126 KB)
  • 129 Views
  • 22 CrossRef citations
  • 0Altmetric
Article
Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma
Stephen K Field MD FRCPC
Pages: 811-818
Published online: 30 Apr 2008
AbstractforRoflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma | Full Text | References | PDF (123.9 KB)
  • 410 Views
  • 30 CrossRef citations
  • 0Altmetric

Key Paper Evaluation

Article
Elocalcitol (BXL-628): a novel, investigational therapy for the therapeutic management of benign prostatic hyperplasia
Evaluation of: Colli E, Rigatti P, Montrosi F, et al. BXL-628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial. Eur J Urol 2006;49:82-6
Atul Tiwari PhD
Pages: 819-824
Published online: 30 Apr 2008
AbstractforElocalcitol (BXL-628): a novel, investigational therapy for the therapeutic management of benign prostatic hyperplasia | Full Text | References | PDF (122.2 KB)
  • 53 Views
  • 1 CrossRef citations
  • 0Altmetric

Corrigendum

Article
Corrigendum
Page: 825
Published online: 30 Apr 2008
CitationforCorrigendum | Full Text | PDF (21.4 KB)
  • 266 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Epidermal growth factor receptor antagonists in colorectal cancer: emerging strategies for precision therapy
Nadia Saoudi González et al.
Review Article | Published online: 22 May 2024
Novel investigational drugs for alopecia areata and future perspectives
Ivana Chim et al.
Review Article | Published online: 20 May 2024
Inflammation and Huntington’s disease- a neglected therapeutic target?
Sophie E. Field et al.
Review Article | Published online: 17 May 2024
Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status
Fernanda Karoline Vieira da Silva Torchelsen et al.
Review Article | Published online: 14 May 2024
View all latest articles